Australian Health Performance Framework: PI 2.1.3c–Cancer screening rates, National Cervical Screening Program participation rate, 2019
Indicator Attributes
Identifying and definitional attributes | |
Metadata item type: | Indicator |
---|---|
Indicator type: | Indicator |
Short name: | AHPF PI 2.1.3c–National Cervical Screening Program participation rate, 2019 |
Synonymous names: | NCSP participation rate |
METEOR identifier: | 723528 |
Registration status: | Health!, Standard 09/04/2020 |
Description: | Rates of cervical screening for women in the national target age group during the defined 24-month period. |
Rationale: | In Australia, primary prevention of cervical cancer is through vaccination against human papillomavirus (HPV), which is the primary underlying cause of cervical cancer. Secondary prevention is by cervical screening, though the National Cervical Screening Program (NCSP), to detect and treat abnormalities while they are in the precancerous stage, prior to any possible progression to cervical cancer. Prior to 1 December 2017, detection of precancerous abnormalities through cervical screening used cytology from the Papanicolaou smear, or 'Pap test', as the screening test. Participation is a major indicator of the performance of the NCSP. High participation in screening is required for the NCSP to achieve its aim of reducing cervical cancer incidence, morbidity and mortality, by detecting and treating cervical abnormalities that could otherwise develop into cervical cancer. Participation is measured over a 2-year period in line with the current recommended screening interval. |
Indicator set: | Australian Health Performance Framework, 2019 Health!, Standard 09/04/2020 |
Collection and usage attributes | |
Population group age from: | 20 years |
---|---|
Population group age to: | 69 years |
Computation description: | The denominator is adjusted to exclude the estimated number of women who have had a hysterectomy, using national hysterectomy fractions. Age-standardised rates are directly age-standardised to the 2001 Australian population. Analysis by Primary Health Network (PHN), remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) is based on postcode of residential address at the time of screening. Presented as a percentage. |
Computation: | 100 × (Numerator ÷ Denominator) |
Numerator: | Number of women aged 20–69 who have been screened in a 2-year period. |
Numerator data elements: | |
Denominator: | Population of women aged 20–69 in each state and territory, geographic region, socio-economic status and Australia, using Australian Bureau of Statistics (ABS) estimated resident population (ERP) for females at 30 June, averaged over the relevant 2 years by age group and adjusted for the estimated proportion of women who have had a hysterectomy |
Denominator data elements: | |
Disaggregation: | 2014–2015, 2015–2016—Nationally, by
2014–2015, 2015–2016—State and territory. 2014–2015, 2015–2016—Primary Health Network (PHN). Data are presented as numbers of participants and participation rates (percentage) including age-specific and age-standardised rates.
Some disaggregation may result in numbers too small for publication. |
Disaggregation data elements: | |
Comments: | Most recent data available for 2019 Australian Health Performance Framework reporting: 2015–2016. |
Representational attributes | |
Representation class: | Percentage |
Data type: | Real |
Unit of measure: | Person |
Format: | NN.N |
Indicator conceptual framework | |
Framework and dimensions: | 1. Effectiveness |
Data source attributes | |
Data sources: | |
Accountability attributes | |
Reporting requirements: | Australian Health Performance Framework |
Organisation responsible for providing data: | Australian Institute of Health and Welfare |
Source and reference attributes | |
Submitting organisation: | Australian Institute of Health and Welfare |
Reference documents: | AIHW (Australian Institute of Health and Welfare) 2014. National cervical cancer prevention data dictionary version 1: working paper. Cancer series no. 88. Cat. no. CAN 85. Canberra: AIHW. Viewed 11 October 2019, https://www.aihw.gov.au/getmedia/b381ba0a-86f6-4603-baa8-66c0f3e4db22/18262.pdf.aspx?inline=true. AIHW 2019. Cervical screening in Australia 2019. Cancer series no. 123. Cat. no. CAN 124. Canberra: AIHW. Viewed 19 November 2019, https://www.aihw.gov.au/reports/cancer-screening/cervical-screening-in-australia-2019/contents/table-of-contents.
|
Relational attributes | |
Related metadata references: | Has been superseded by Australian Health Performance Framework: PI 2.1.3c–Cancer screening rates, National Cervical Screening Program participation rate, 2020 Health!, Standard 13/10/2021 |